Pfizer Ltd. — Board/Management Information 2023

Oct 28, 2023

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901,

Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

October 28, 2023

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure − Requirements) Regulations, 2015 Appointment of Mr. P. Rengan as Executive Director – Plant Operations.

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today appointed Mr. P. Rengan (DIN: 10362899) as an Additional Director of the Company, designated as Executive Director – Plant Operations, for a period of 5 years with effect from October 28, 2023. The appointment of Mr. Rengan will be subject to the approval of shareholders through Postal Ballot.

Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and List/Comp/14/2018-19 dated June 20, 2018, are enclosed as Annexure A.

Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2023.10.28 15:17:07 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

Encl: A/a

CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerltd.co.in

ANNEXURE A

Additional details of Mr. P Rengan

Sr. no.	Particulars	Details
1.	Reasons for change	Fresh Appointment
2.	Date of Appointment and Term	5 (Five) years effective October 28, 2023
3.	Affirmation as per List/Comp/14/2018-19 dated June 20, 2018	We hereby affirm that Mr. P Rengan is not debarred or disqualified from holding the office of Director by virtue of any order from MCA/SEBI or any other such statutory authority.
4.	Relationship Inter-se Directors/ Key Managerial Personnel	Mr. P Rengan is not related to any of the Directors/Key Managerial Personnel
5.	Number of Shares held in the Company	NIL
6.	Brief Profile	Mr. P Rengan is a Pharmaceutical Professional with over 20 years of experience in site operations and manufacturing & packaging operations and is the Senior Director – Plant Operations of Company’s Manufacturing facility at Goa. Mr. Rengan is a Master of Technology in Pharmaceutical Operations & Management from Birla Institute of Technology & Science, Pilani, Master of Business Administration from Annamalai University and a Bachelor of Pharmacy from Dr. M.G.R. Medical University. Mr. Rengan joined the Company’s Manufacturing site at Goa in 2004. During his tenure with the Company, Mr. Rengan has held several positions of increasing responsibility across a number of functions, including Production; Environment, Health & Safety; and Operational Excellence. Mr. P Rengan was awarded with the Global Best Practice Award by Wyeth LLC for developing and implementing the Skill-Will Competency-based Training system for critical manufacturing operation. Mr. Rengan has also conducted Global Audits in Indonesia, China and Singapore. His experience and demonstrated performance in multiple functions and support in strategic projects provide him with a strong foundation for his role as Executive Director – Plant Operations. Mr. P Rengan does not hold Directorship in any other Company.